No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer

Breast Cancer Research and Treatment

Volumn 124, Issue 3, 2010, Pages 853-856

  Huang, Katie T ^a,b   Dobrovic, Alexander ^a,b   Fox, Stephen B ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer; DNA methylation; Hypoxia; VHL ubiquitin ligase complex

Indexed keywords

CULLIN 2; DNA; ELONGIN C; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RING BOX 1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU UBIQUITIN LIGASE COMPLEX;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; CUL2 GENE; DNA METHYLATION; GENE SILENCING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RBX1 GENE; TCEB1 GENE; TCEB2 GENE; TUMOR GENE; UPREGULATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, RENAL CELL; CARRIER PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; CULLIN PROTEINS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 78649323616     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1087-5     Document Type: Article

References (11)

1. ME Cockman N Masson DR Mole, et al. 2000 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 33 25733 25741 1:CAS:528:DC%2BD3cXmtVeht7o%3D 10.1074/jbc. M002740200 10823831
2. AL Harris 2002 Hypoxia-a key regulatory factor in tumour growth Nat Rev Cancer 2 1 38 47 1:CAS:528:DC%2BD38XhvF2jtL4%3D 10.1038/nrc704 11902584
3. GL Semenza 2003 Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 10 721 732 1:CAS:528:DC%2BD3sXotFCiu70%3D 10.1038/nrc1187 13130303
4. RE Banks P Tirukonda C Taylor, et al. 2006 Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer Cancer Res 66 4 2000 2011 1:CAS:528:DC%2BD28XhsFamurY%3D 10.1158/0008-5472.CAN-05-3074 16488999
5. JJ Patard N Rioux-Leclercq D Masson, et al. 2009 Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma Br J Cancer 101 8 1417 1424 1:CAS:528:DC%2BD1MXht1Gnur7O 10.1038/sj.bjc.6605298 19755989
6. JG Herman F Latif Y Weng, et al. 1994 Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci USA 91 21 9700 9704 1:CAS:528:DyaK2cXmvFCgsLs%3D 10.1073/pnas.91.21.9700 7937876 (Pubitemid 24311875)
7. E Hatzimichael G Dranitsaris A Dasoula, et al. 2009 Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease Clin Lymphoma Myeloma 9 3 239 242 1:CAS:528:DC%2BD1MXosVerurY%3D 10.3816/CLM.2009.n.047 19525194
8. Wojdacz TK, Dobrovic A (2007) Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucl Acids Res 35(6):e41
9. G Sourvinos S Miyakis TL Liloglou, et al. 2001 Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer Tumour Biol 22 3 131 136 1:CAS:528:DC%2BD3MXjtFyjurw%3D 10.1159/000050607 11275790 (Pubitemid 32245408)
10. MK Zia KA Rmali G Watkins, et al. 2007 The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells Int J Mol Med 20 4 605 611 1:CAS:528:DC%2BD2sXht1Srt7nM 17786294
11. SW Park NG Chung SY Hur, et al. 2009 Mutational analysis of hypoxia-related genes HIF1alpha and CUL2 in common human cancers APMIS 117 12 880 885 1:CAS:528:DC%2BC3cXisVCguw%3D%3D 10.1111/j.1600-0463.2009.02550.x 20078552